SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2022

SEGMENTS [Abstract]

Summarized Financial Information Concerning Reportable Segments

Summarized financial information concerning reportable segments is shown in the following tables:

Year Ended December 31, 2022
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	144,069,543		$	9,867,315		$	142,834		$	154,079,692
Cost of product revenue		108,881,938			9,932,597			-			118,814,535
Income (loss) from operations		879,387			(17,908,378	)		(22,336,089	)		(39,365,080	)
Interest and other expense, net		(504,787	)		(3,266	)		(19,360,876	)		(19,868,929	)
Loss on extinguishment of debt		-			-			(6,669,941	)		(6,669,941	)
Net income (loss)		374,600			(17,911,644	)		(48,366,906	)		(65,903,950	)
Capital expenditures		5,246,860			8,664,311			-			13,911,171
Depreciation and amortization expense		4,708,879			2,403,572			918			7,113,369
Total assets		238,159,534			37,070,535			73,231,812			348,461,881

Year Ended December 31, 2021
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	74,935,528		$	5,864,263		$	142,834		$	80,942,625
Cost of product revenue		74,124,999			5,644,342			-			79,769,341
Loss from operations		(29,293,309	)		(12,056,364	)		(17,024,068	)		(58,373,741	)
Interest and other expense, net		(218,053	)		(5,660	)		(13,050,164	)		(13,273,877	)
Net loss		(29,511,362	)		(12,062,024	)		(30,074,232	)		(71,647,618	)
Capital expenditures		4,876,983			8,634,275			-			13,511,258
Depreciation and amortization expense		4,217,771			1,272,397			5,334			5,495,502
Total assets		208,391,019			24,681,691			43,180,014			276,252,724